An injunction is the only remedy against anticompetitive effects that would emerge from UnitedHealth Group’s proposed $13 billion acquisition of Change Healthcare, as the deal will result in a “real monopoly” and harms competition, the US Department of Justice told a federal court judge.Counsel for the DOJ told US District Judge Carl